US$ 23.99
dihexa human trials trial dihexa human status 2026 SCOPE 2026, Simplified Patient Recruitment Management, AI Powered Clinical Trial Finders and More… – TrialX dihexa clinical trials status 2026
Description
Randomized controlled trial: subcutaneous vs intravenous infliximab CT-P13 maintenance in inflammatory bowel disease

305 , R147R156 (2013)

(216) utilized C57BL/6J mice to induce a model of SSc, confirming that mesenchymal stem cells (MSCs) alleviate SSc symptoms by modulating the balance of the gut microbiota

Purity Standards Maintaining high purity is essential for meaningful scientific investigation
